Atlas Trials

This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

Clinical trial NCT05082428 · COMPLETED

Trial details

NCT number
NCT05082428
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Ulcerative Colitis
Start date
2022-05-30
Primary completion
2022-11-01
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.